Research Paper Volume 13, Issue 9 pp 12849—12864

The prognostic and immunological effects of ZBTB7C across cancers: friend or foe?

(A–C) The differential expression of ZBTB7C and immune markers in colorectal cancer and adjacent tissues. (A) From the TCGA. (B) From the GEO. (C) Seventeen pairs of colorectal cancer tissues and adjacent tissues from the First Affiliated Hospital of Chongqing Medical University. (D–H) Expression of (D) TPSB2, (E) MS4A2, (G) CD19 and (H) MS4A1 in cancer and adjacent tissues. (F, I) Survival curve of immune cells in colorectal cancer.

Figure 6. (AC) The differential expression of ZBTB7C and immune markers in colorectal cancer and adjacent tissues. (A) From the TCGA. (B) From the GEO. (C) Seventeen pairs of colorectal cancer tissues and adjacent tissues from the First Affiliated Hospital of Chongqing Medical University. (DH) Expression of (D) TPSB2, (E) MS4A2, (G) CD19 and (H) MS4A1 in cancer and adjacent tissues. (F, I) Survival curve of immune cells in colorectal cancer.